SCHEMBL12656063

SCHEMBL12656063

CC(=O)c1ccc(S(=O)(=O)N2CCC3(CC2)NC(=O)C(Cc2c[nH]cn2)N3S(=O)(=O)c2ccc(C(C)=O)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.43
▸ ALDH1A1 P00352 4/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GFER P55789 1/20 0.39
▸ ATM Q13315 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ IKBKB O14920 1/20 0.36
▸ CHUK O15111 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ NEK2 P51955 1/20 0.36
▸ EPHX2 P34913 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12656338 0.94 LMNA (0.41) LMNAALDH1A1RAB9ANPC1MAPT
SCHEMBL12656286 0.90 ALDH1A1 (0.40) LMNAALDH1A1RAB9ANPC1MAPT
SCHEMBL12656195 0.89 RAB9A (0.34) LMNAALDH1A1RAB9ANPC1MAPT
SCHEMBL13363631 0.88 GPR119 (0.39) —
SCHEMBL21202625 0.84 GLA (0.38) LMNAALDH1A1MAPTSMN1; SMN2KMT2A
SCHEMBL12622197 0.83 ALDH1A1 (0.42) LMNAALDH1A1RAB9ANPC1MAPT
SCHEMBL21325177 0.81 HSD11B1 (0.34) —
SCHEMBL12626404 0.80 LMNA (0.43) LMNAALDH1A1RAB9ANPC1MAPT
SCHEMBL12623912 0.78 HRH3 (0.41) LMNAALDH1A1RAB9ANPC1MAPT
SCHEMBL12662918 0.74 ALDH1A1 (0.39) LMNAALDH1A1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580809-B2 Filamin A-binding anti-inflammatory analgesic PAIN THERAPEUTICS, INC. (US) 2013-11-12 — — US disclosed
US-8580808-B2 Filamin A-binding anti-inflammatory analgesic Pain Therapeutic, Inc. (US) 2013-11-12 — — US disclosed
US-20110105484-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC PAIN THERAPEUTICS 2011-05-05 — — US disclosed
US-20110105547-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC PAIN THERAPEUTICS 2011-05-05 — — US disclosed
WO-2010051476-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC PAIN THERAPEUTICS, INC. (US) 2010-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105484-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC FLNA, FLNB, OPRK1 LMNA 216/4885ALDH1A1 2702/4885RAB9A 1724/4885
US-20110105547-A1 FILAMIN A-BINDING ANTI-INFLAMMATORY ANALGESIC FLNA, FLNB, OPRK1 LMNA 216/4885ALDH1A1 2702/4885RAB9A 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback